Suppliers

EFSA rejects Merck glucosamine-joint health claim

EFSA health claim opinion

EFSA rejects Merck glucosamine-joint health claim

Glucosamine does not help maintain normal joint cartilage, the European Food Safety Authority (EFSA) has found after assessing a proprietary article 13.5 dossier submitted by drug giant, Merck Consumer Healthcare.

ONC is strong in omega-3 supplements, but could drug apps hold greater promise?

DSM eyes generic omega-3 drug space with €420m ONC buy

By Shane Starling

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

LycoRed is conducting continuous research into the health benefits of tomato extract

LycoRed to target Eastern Europe

By Rod Addy

LycoRed plans to target Eastern Europe for sales growth, according to newly appointed global vice president of marketing and sales for Europe, Middle East and Africa Frederic Nanquette.

Frutarom rolls out “winter ailment” herb and mineral suite

Frutarom rolls out “winter ailment” herb and mineral suite

By Lynda Searby

Consumer concerns about drug resistance, promising market data and interest from the industry in established, ‘safe’ ingredients with EFSA-approved claims are behind Frutarom’s decision to roll out a range of ingredients addressing immune health.

What kind of health claims will be made on the Vitafoods show floor this year?

Vitafoods: EU nutra space wriggles into new health claims clothes

By Shane Starling

Vitafoods celebrates its 15th birthday next week. It’ll be my 11th consecutive May visit to Geneva for the jamboree and promises to be one of the most intriguing chapters with the (partial and belated) resolution of years of ambiguity regarding health...

Prawn peptides are ACE for blood pressure: Rat study

Prawn peptides are ACE for blood pressure: Rat study

By Shane Starling

Peptide extracts from the Arctic prawn Pandalus Borealis have demonstrated blood pressure benefits via the, “most potent Angiotensin Converting Enzyme (ACE) inhibiting peptide concentrate that is reported in scientific literature.”

BfR's warning against excessive nicotinic acid consumption isn't new, according to an industry expert

Excessive nicotinic acid intake is damaging to health: BfR

By Kacey Culliney

The BfR – Germany’s Federal Institute for Risk Assessment – has called on consumers to refrain from taking nicotinic acid in excessive dosages as it is ‘damaging’ to health even if it is not widely used in Europe, according to an industry expert.

VSI's new factory can even make triple-layered bars

Dutch bar manufacturer VSI opens third factory

By Rod Addy

Dutch non-branded bar manufacturer VSI has begun operations at a €10m plant in Leerdam, Holland, which incorporates a research and development (R&D) centre and has the capacity to make triple-layered bars.

Israeli krill player doubles capacity

Israeli krill player doubles capacity

By Shane Starling

Israeli lipid specialist Enzymotec has doubled its krill production capacity to an unspecified level as it responds to growing global demand for the Antarctic micro-shrimp that is registering at about 30% per annum.

How should products manufactured outside the EU be regulated online within the bloc?

Who is regulating EU cyber supplement sales?

By Luca Bucchini, PhD

Food supplements are ideally suited for online sales: stable, light, high-value, popular with consumers. It is therefore no surprise that online food supplement sales are on the rise with the promise of lower prices and home delivery.

Rejected cranberry wins EU medical UTI claim

By Shane Starling

€3 million and seven years of research and development work have paid off for Medical Brands which has won the right to make medical urinary tract infection (UTI) claims in the EU and beyond with its cranberry partner, Decas Botanical Synergies (DBS).

The FDA has acted against products containing DMAA like Jack3D

EU authorities set to follow US DMAA alarm

By Shane Starling

European food and medicines agencies will follow the lead of the US Food and Drug Administration (FDA) which last week issued warning letters to 10 manufacturers over safety and authenticity concerns for DMAA products, an EU food law expert has said.

Follow us

Products

View more

Webinars